1 13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment.

2 Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.

3 Addressing the impact of the Coronavirus Disease (COVID-19) pandemic on hematopoietic cell transplantation: Learning networks as means for sharing best practices.

4 Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.

5 case of early-disseminated rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient

6 pseudomembranous tracheitis caused by aspergillus fumigatus in the setting of high grade t-cell lymphoma

7 pulmonary nocardiosis and scrub typhus in an immunocompromised host

8 parasites may exit immunocompromised northern pig-tailed macaques (macaca leonina) infected with sivmac239

9 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

10 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

11 Staphylococcus aureus – antimicrobial resistance and the immunocompromised child

12 Current management of parainfluenza pneumonitis in immunocompromised patients: a review

13 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

14 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

15 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

16 Staphylococcus aureus – antimicrobial resistance and the immunocompromised child

17 Current management of parainfluenza pneumonitis in immunocompromised patients: a review

18 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

19 Kaposi Sarcoma in Non-immunocompromised Adult.

20 Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children.

21 Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

22 Molecular epidemiology of Enterocytozoon bieneusi and Encephalitozoon sp., among immunocompromised and immunocompetent subjects in Iran

23 Emerging Antimicrobial Resistance and the Immunocompromised Host

24 Viral infections in immunocompromised patients: what's new with respiratory viruses?

25 Community respiratory virus infections in immunocompromised patients with cancer

26 Hepatic candidiasis: an increasing problem in immunocompromised patients

27 Fever in immunocompromised patients

28 Severe RSV bronchiolitis in an immunocompromised child

29 Dermatologic infections in the immunocompromised (non-HIV) host

30 molecular and conventional methods for detection of candida species isolated from a sample of immunocompromised iraqi patients with pulmonary symptoms

31 invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients

32 immunocompromised host: from the early events until the impact of acquired immunodeficiency syndrome

33 necrobiosis lipoidica developing within a surgical scar in a non-diabetic patient: type iii koebner phenomenon (isomorphic response), wolf's isotopic response or ruocco's immunocompromised cutaneous district?

34 myroides odoratus and chryseobacterium indologenes: two rare isolates in the immunocompromised

35 prevalence of enteroparasites in immunocompromised and immunocompetent children

36 molecular detection of pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of iran

37 tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infecções fúngicas treatment by fluconazole of severe fungal infections in immunocompromised patients

38 treatment of immunocompromised, critically ill patients with influenza a h1n1 infection with a combination of oseltamivir, amantadine, and zanamivir

39 cd4+ and cd8+ t cell immune responses of immunocompetent and immunocompromised (aids) patients with american tegumentary leishmaniasis

40 antifungal prophylaxis in immunocompromised patients

41 disseminated tuberculosis with prostatic abscesses in an immunocompromised patient—a case report and review of literature

42 a rare case of immune reconstitution inflammatory syndrome development in an immunocompromised patient with progressive multifocal leukoencephalopathy and multicentric castleman’s disease

43 correct identification of ochrobactrum anthropi from blood culture using 16rrna sequencing: a first case report in an immunocompromised patient in mexico

44 isoscartopic response: another facet of the immunocompromised cutaneous district

45 Searching for a Bacteriophage Lysin to Treat in Immunocompromised Mice.

46 Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 in Highly Immunocompromised Strains of Mice.

47 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus

48 Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011–2015

49 Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure

50 Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure

51 An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients

52 Diagnosis of severe respiratory infections in immunocompromised patients

53 Acute respiratory failure in immunocompromised adults

54 High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

55 Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs

56 Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial

57 Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs

58 The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial - Critical Care

59 Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis

60 The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts

61 The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts

62 Viral community-acquired pneumonia in nonimmunocompromised adults

63 Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs

64 Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

65 Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure - Annals of Intensive Care

66 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

67 The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

68 Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial

69 The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

70 Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children

71 Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

72 DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study

Keyword Connections

Journals

Research Groups

Bibliographies